SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Preventive Visit — Marilyn Monroe — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientMarilyn Monroe
Date of birth1926-06-01
IdentifiersMRN HR-ML002-SYN-TD; SSN (made up) 000-02-4471
Document date1956-08-17
AuthorJoanna Whitlock, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Periodic adult preventive visit, with pregnancy planning. [S]

History of Present Illness

Ms. Monroe is a 30-year-old actor who comes for her yearly preventive visit, nine weeks after her first visit for painful periods. Endometriosis with a left ovarian endometrioma was diagnosed by ultrasound at the gynecology consultation. On the continuous combined pill she has had no periods, only two days of light spotting, and her worst pelvic pain has fallen; she has used naproxen on only a few days. Pain with deep intercourse persists. The bladder infection last month cleared within two days of nitrofurantoin. She has had six sessions of cognitive behavioral therapy, sleeps better, and stopped diphenhydramine. She married this summer. She would like to try for a pregnancy in about a year and wants to know what to do before then. Her PHQ-9 today is 8. [S]

ElementDetail
VisitPeriodic adult preventive visit, age 30
EndometriosisNo periods on the continuous pill; less pain; deep pain with intercourse persists
Pregnancy plansWould like to try in about a year
MoodPHQ-9 8, from 12; item 9 scored 0; six therapy sessions
SleepBetter; diphenhydramine stopped

Health risk assessment. Completed by the patient on a tablet in the waiting room and reviewed with her by Dr. Whitlock. [S]

DomainFinding
Self-rated healthGood, better than in the spring
PsychosocialSupported by her spouse and a close friend; working again without missed days this month
Substance useAUDIT-C 2; no drugs; no opioid or sedative use
TobaccoNever smoked
Physical activityWalks 30 to 40 minutes most days; dance and movement classes for work
NutritionRegular meals; dairy or fortified foods daily
SleepSeven hours most nights, at regular times
Sexual and reproductive healthOne male partner, her spouse; continuous combined pill; would like a pregnancy in about a year
Safety at homeFeels safe; no one hurts, threatens, or controls her; no firearm in the home
Road safetyWears a seat belt
Activities of daily livingIndependent

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever, weight change, or night sweats
EyesNegativeNo vision change
Ears, nose, mouth, and throatNegativeNo hearing change or sore throat
CardiovascularNegativeNo chest pain, palpitations, or leg swelling
RespiratoryNegativeNo cough or breathlessness
GastrointestinalNegativeNo painful bowel movements since the periods stopped; no bleeding
GenitourinaryPositiveDeep pain with intercourse; no periods, two days of light spotting; no urinary symptoms since the infection cleared
MusculoskeletalNegativeNo joint pain
IntegumentaryNegativeNo changing moles or rash
NeurologicalNegativeNo headaches, migraine, or visual aura on the pill
EndocrineNegativeNo heat or cold intolerance
PsychiatricPositiveMood improving; PHQ-9 score 8; no thoughts of suicide or self-harm

12 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Naproxen 500 mg oral tablet, one tablet by mouth twice daily with food, from two days before an expected bleed until the third day, and for pain flares; no more than 10 days a monthOne tablet by mouth twice daily with food when needed for pelvic painOral route1956-06-15activeS
Ethinyl estradiol 0.02 mg and norethindrone acetate 1 mg oral tablet, one tablet by mouth daily, taken continuously without a pill-free weekOne tablet by mouth daily, continuouslyOral route1956-06-15activeS
Nitrofurantoin (monohydrate and macrocrystals) 100 mg oral capsule, one capsule by mouth twice daily with food for 5 daysOne capsule by mouth twice daily with food for 5 daysOral route1956-07-20 to 1956-07-24completedS
Folic acid 0.4 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1956-08-17activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1956-08-17Body height166cmS
1956-08-17Body weight56.6kgS
1956-08-17Body mass index (BMI) [Ratio]20.5kg/m2S
1956-08-17Systolic blood pressure110mm[Hg]S
1956-08-17Diastolic blood pressure70mm[Hg]S
1956-08-17Heart rate72/minS
1956-08-17Respiratory rate14/minS
1956-08-17Body temperature36.6CelS
1956-08-17Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1956-08-17Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]8{score}S
1956-08-17Total score [AUDIT-C]2{score}S

Physical Exam

Vital signs recorded on 1956-08-17; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell; weight 56.6 kg, BMI 20.5; blood pressure 110/70
NeckThyroid normal; no lymph nodes
CardiovascularRegular rhythm; no murmur; no leg swelling
RespiratoryClear to auscultation bilaterally
AbdomenSoft; mild left lower quadrant tenderness only on deep palpation
PelvicNormal external genitalia, vagina, and cervix. Primary HPV sample collected from the cervix. Bimanual examination deferred to the endometriosis review in four weeks at her request
SkinNo suspicious lesions
PsychiatricBrighter, engaged; organized; no psychotic or manic features

Problems

ProblemClinical statusVerificationCodeProvenance
Severe painful periods since her teens, worse over the past three years, with pelvic pain between periods, deep pain with intercourse, and painful bowel movements during periods; she misses work for two or three days each cycle. Tender, slightly fixed retroverted uterus with tenderness and fullness in the left adnexa and along the left uterosacral ligament. Suspected endometriosis; transvaginal ultrasound and gynecology consultation bookedresolvedconfirmed N94.6S — Synthetic presenting problem linked to her documented endometriosis; superseded by the diagnosis at the consultation.
Endometriosis: a 3.4 cm left ovarian endometrioma on transvaginal ultrasound, with a tender, thickened left uterosacral ligament and no deep nodule of the bowel or bladder seen; diagnosed from imaging and examination without surgery, as the ESHRE guideline allows. Synthetic modern episode linked to her documented endometriosisactiveconfirmed N80.102S — Synthetic modern diagnosis made at the gynecology consultation; depth is unspecified because no surgery was done.
Major depressive disorder, single episode, moderate: about two months of low mood, poor sleep on painful nights, low energy, guilt about missed work, and poor concentration (PHQ-9 12, item 9 scored 0; GAD-7 8); Mood Disorder Questionnaire negative; no thoughts of suicide or self-harmactiveconfirmed F32.1S — Synthetic modern diagnosis; the historical and retrospective mental-health accounts are not coded.
Acute uncomplicated cystitis: one day of burning, frequency and urgency with suprapubic discomfort, without fever, flank pain or blood in the urine; urine dipstick positive for leukocyte esterase and nitrite; culture grew Escherichia coli sensitive to nitrofurantoin; resolvedactiveconfirmed N30.00S — Synthetic acute infection; not a historical claim.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Blood pressure screeningCompleted today110/70 mmHg
Depression screeningCompleted todayPHQ-9 score 8, from 12 at intake; item 9 scored 0; under treatment
Anxiety screeningUp to dateGAD-7 8 at intake; repeated at the endometriosis reviews
Unhealthy alcohol use screeningCompleted todayAUDIT-C score 2
Tobacco useCompleted todayNever smoked
Cervical cancer screeningOrderedLast cytology four years ago was normal; primary HPV test collected today, every five years if negative
Contraception and pregnancy intentionCompleted todayWould like a pregnancy in about a year; continuous combined pill continued for endometriosis pain and contraception until then; no condition that rules out estrogen
Folic acidCompleted today0.4 mg daily started for a woman planning a pregnancy
Intimate partner violence screeningCompleted todayNegative; she feels safe
Chlamydia and gonorrhea screeningUp to dateNegative at the first visit as part of the pelvic pain evaluation; one partner
HIV and hepatitis C screeningOrderedNo result on record; once-in-a-lifetime tests drawn today with her agreement
Diabetes and cholesterol screeningNot indicatedAge 30 with a BMI of 20.5 and no risk factors
Influenza vaccineDueTo be given at the next visit, when the autumn supply arrives
COVID-19 vaccineDueDiscussed; she will decide at the next visit
Tetanus, diphtheria, and pertussisUp to dateTdap five years ago; Tdap again in each pregnancy
Measles, mumps, rubella and varicellaUp to dateTwo documented doses of each; immune before pregnancy
HPV vaccineUp to dateSeries completed in adolescence

Guideline basis: U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 (2024); U.S. Selected Practice Recommendations for Contraceptive Use, 2024 (2024); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Medical Condition and Other Indication (2026)

Follow-up: HPV, HIV, and hepatitis C results by phone. Endometriosis review in four weeks with a pelvic examination, PHQ-9, GAD-7, and the influenza vaccine. Next preventive visit in one year. Next scheduled visit 1956-09-14: three-month review on continuous hormonal treatment: pain, bleeding, mood, and pain with intercourse. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 16 minutes, with her consent. She named a health care agent, recorded in the confidential part of the chart and not named here, and said that if she were ever too ill to decide, she would want her agent to know her wish to keep the chance of having children wherever possible. She chose not to record other treatment preferences today. To be revisited yearly. [S]